Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.950
-0.010 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
1.940
-0.010 (-0.51%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Palisade Bio Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Palisade Bio stock have an average target of 11.29, with a low estimate of 5.00 and a high estimate of 25. The average target predicts an increase of 478.97% from the current stock price of 1.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palisade Bio stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 5 | 5 |
| Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $7 | Buy | Initiates | $7 | +258.97% | Apr 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +258.97% | Mar 26, 2026 |
| Stifel | Stifel | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +156.41% | Feb 25, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +258.97% | Jan 9, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +515.38% | Dec 30, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.23
from -0.30
EPS Next Year
-0.28
from -0.23
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.07 | -0.13 | ||||||
| Avg | -0.23 | -0.28 | ||||||
| Low | -0.32 | -0.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.